drugset / Trial / NCT00551135

Surgical Pain After Inguinal Hernia Repair (SPAIHR)

NCT00551135

Phase 3 Completed 425 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test whether pregabalin added to the standard of care with dosing starting preoperatively and continuing for 1 week post surgery will decrease the intensity of acute post-operative pain following inguinal hernia repair.

Timeline

Start
2008-01
Primary completion
2009-06
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 25 mg
Subject Pregabalin Small molecule 75 mg
Subject Pregabalin Small molecule 150 mg

Indications